NCT05283317View on ClinicalTrials.gov

Effect of Mesenchymal Stromal Cells on Sepsis and Septic Shock

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 11, 2018

Primary Completion Date

August 25, 2019

Study Completion Date

November 13, 2019

Conditions
SepsisSeptic Shock
Interventions
BIOLOGICAL

Mesenchymal stem cells

Standard therapy of sepsis as suggested in the guidelines were given to all patients and additionally MSCs treatment was applied to the patients in the study group.

Trial Locations (1)

Unknown

Erciyes University, Kayseri

All Listed Sponsors
lead

TC Erciyes University

OTHER

NCT05283317 - Effect of Mesenchymal Stromal Cells on Sepsis and Septic Shock | Biotech Hunter | Biotech Hunter